1460775808-b68865f2-a733-4938-970a-c1f64e9f6301

What is claimed is:

1. A Composition of traditional Chinese medicines comprising at least six of the following eight traditional Chinese medicines: Ren Shen, Dang Gui, Huang Qi, Gan Cao, Chai Hu, Huang Lian, Tian Zhu Huang, Huang Qin.
2. The composition according to claim 1 comprising at least seven of said eight traditional Chinese medicines.
3. The composition according to claim 2 comprising said eight traditional Chinese medicines.
4. The composition according to claim 1, wherein said eight traditional Chinese medicines are in the form of dry powder.
5. The composition according to claim 4, wherein said eight traditional Chinese medicines are in a weight ratio of Ren Shen: Dang Gui: Huang Qi: Gan Cao: Chai Hu: Huang Lian: Tian Zhu Huang: Huang Qin14010%: 16610%: 18010%: 6710%: 14010%: 12010%: 12010%: 6710%, wherein amounts of one or two of said eight traditional Chinese medicines are zero, while the weight ratio of the others remaining unchanged, in the case when said composition comprises six or seven of said eight traditional Chinese medicines.
6. A pharmaceutical composition for inhibiting platelet aggregation comprising at least six of the following eight traditional Chinese medicines: Ren Shen, Dang Gui, Huang Qi, Gan Cao, Chai Hu, Huang Lian, Tian Zhu Huang, Huang Qin as active ingredients.
7. The pharmaceutical composition according to claim 6 comprising at least seven of said eight traditional Chinese medicines.
8. The pharmaceutical composition according to claim 7 comprising said eight traditional Chinese medicines.
9. The pharmaceutical composition according to claim 6, wherein said eight traditional Chinese medicines are in the form of dry powder.
10. The pharmaceutical composition according to claim 9, wherein said eight traditional Chinese medicines are in a weight ratio of Ren Shen: Dang Gui: Huang Qi: Gan Cao: Chai Hu: Huang Lian: Tian Zhu Huang: Huang Qin14010%: 16610%: 18010%: 6710%: 14010%: 12010%: 12010%: 6710%, wherein amounts of one or two of said eight traditional Chinese medicines are zero, while the weight ratio of the others remaining unchanged, in the case when said pharmaceutical composition comprises six or seven of said eight traditional Chinese medicines.
11. A pharmaceutical composition for prolonging bleeding time in a patient comprising at least six of the following eight traditional Chinese medicines: Ren Shen, Dang Gui, Huang Qi, Gan Cao, Chai Hu, Huang Lian, Tian Zhu Huang, Huang Qin as active ingredients.
12. The pharmaceutical composition according to claim 11 comprising at least seven of said eight traditional Chinese medicines.
13. The pharmaceutical composition according to claim 12 comprising said eight traditional Chinese medicines.
14. The pharmaceutical composition according to claim 11, wherein said eight traditional Chinese medicines are in the form of dry powder.
15. The pharmaceutical composition according to claim 14, wherein said eight traditional Chinese medicines are in a weight ratio of Ren Shen: Dang Gui: Huang Qi: Gan Cao: Chai Hu: Huang Lian: Tian Zhu Huang: Huang Qin14010%: 16610%: 18010%: 6710%: 14010%: 12010%: 12010%: 6710%, wherein amounts of one or two of said eight traditional Chinese medicines are zero, while the weight ratio of the others remaining unchanged, in the case when said pharmaceutical composition comprises six or seven of said eight traditional Chinese medicines.
16. A pharmaceutical composition for preventing and treating a cerebrovascular disease in a patient comprising at least six of the following eight traditional Chinese medicines: Ren Shen, Dang Gui, Huang Qi, Gan Cao, Chai Hu, Huang Lian, Tian Zhu Huang, Huang Qin as active ingredients.
17. The pharmaceutical composition according to claim 16 comprising at least seven of said eight traditional Chinese medicines.
18. The pharmaceutical composition according to claim 17 comprising said eight traditional Chinese medicines.
19. The pharmaceutical composition according to claim 16, wherein said eight traditional Chinese medicines are in the form of dry powder.
20. The pharmaceutical composition according to claim 19, wherein said eight traditional Chinese medicines are in a weight ratio of Ren Shen: Dang Gui: Huang Qi: Gan Cao: Chai Hu: Huang Lian: Tian Zhu Huang: Huang Qin14010%: 16610%: 18010%: 6710%: 14010%: 12010%: 12010%: 6710%, wherein amounts of one or two of said eight traditional Chinese medicines are zero, while the weight ratio of the others remaining unchanged, in the case when said pharmaceutical composition comprises six or seven of said eight traditional Chinese medicines.
21. The pharmaceutical composition according to claim 16, wherein said cerebrovascular disease is an ischemic cerebrovascular disease.
22. The composition according to claim 5, which is administered orally.
23. The pharmaceutical composition according to claim 10, which is administered orally.
24. The pharmaceutical composition according to claim 15, which is administered orally.
25. The pharmaceutical composition according to claim 20, which is administered orally.
26. A method of preventing and treating cerebrovascular disease in a patient, which comprises administering to the patient a therapeutically-effective amount of a composition of traditional Chinese medicines comprising at least six of the following eight traditional Chinese medicines: Ren Shen, Dang Gui, Huang Qi, Gan Cao, Chai Hu, Huang Lian, Tian Zhu Huang, Huang Qin.
27. The method according to claim 26, wherein said composition comprises at least seven of said eight traditional Chinese medicines.
28. The method according to claim 27, wherein said composition comprises said eight traditional Chinese medicines.
29. The method according to claim 26, wherein said eight traditional Chinese medicines are in the form of dry powder.
30. The method according to claim 29, wherein said eight traditional Chinese medicines are in a weight ratio of Ren Shen: Dang Gui: Huang Qi: Gan Cao: Chai Hu: Huang Lian: Tian Zhu Huang: Huang Qin14010%: 16610%: 18010%: 6710%: 14010%: 12010%: 12010%: 6710%, wherein amounts of one or two of said eight traditional Chinese medicines are zero, while the weight ratio of the others remaining unchanged, in the case when said traditional Chinese medicines comprises six or seven of said eight traditional Chinese medicines.
31. The method according to claim 26, wherein said cerebrovascular disease is an ischemic cerebrovascular disease.
32. The method according to claim 30, wherein said composition is administered orally.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A method of synchronizing data records stored in a first and second database, comprising the steps of:
associating a pair of synchronization parameters with each data record stored in the first and second databases, the pair including a first synchronization parameter associated with the first database, and a second synchronization parameter associated with the second database;
updating a data record at the first database;
incrementing the first synchronization parameter associated with the updated data record at the first database;
transmitting a first update message from the first database to the second database, the first update message including the incremented first synchronization parameter, the second synchronization parameter, and the updated data record from the first database;
receiving the first update message at the second database; and
updating the data record at the second database using the information from the first update message.